Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 10925975
Acidic nanoparticles for restoration of autophagy
granted -
US 10925961
Vaccines with CD40 ligand as an adjuvant
granted -
US 10925946
Vaccination methods
granted -
US 10925972
Glycan-dependent immunotherapeutic molecules
granted -
US 10925971
Methods of treating PRLR positive breast cancer
granted -
US 10925928
Method for treating chemotherapy-induced male infertility
granted -
US 10925923
Peptide having anti-inflammatory activity, and use thereof
granted -
US 10925874
Substituted pyrazolopyrimidines as glucocerebrosidase activators
granted -
US 10925860
Compositions and methods of treating cardiac fibrosis with ifetroban
granted -
US 10925879
Methods of treating developmental disorders and/or seizure disorders with etifoxine
granted -
US 10925851
Use of Tosedostat and related compounds as analgesics
granted -
US 10927349
Platform for generating safe cell therapeutics
granted -
US 10927130
Isothiazolopyrimidinones, pyrazolopyrimidinones, and pyrrolopyrimidinones as ubiquitin-specific protease 7 inhibitors
granted -
US 10927182
Humanized BCMA antibody and BCMA-CAR-T cells
granted -
US 10927374
Compositions and methods for controlling arthropod parasite and pest infestations
granted -
US 10925969
Anti-BCMA polypeptides and proteins
granted -
US 10925945
Bacterial vaccines deficient in the 2-C-methyl-D-erythritol-4-phosphate pathway and methods of preparation and use thereof
granted -
US 10925902
Genetically engineered hematopoietic stem cells and uses thereof
granted -
US 10925977
Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
granted -
US 10918722
Pharmaceutical compositions comprising meloxicam
granted -
US 10918657
Treatment of spinal cord injury or traumatic brain injury by inhibition of synuclein protein aggregation
granted -
US 10918668
Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases
granted -
US 10919877
Multifunctional inhibitors of MEK/PI3K and mTOR/MEK/PI3K biological pathways and therapeutic methods using the same
granted -
US 10918594
Controlled-release CNS modulating compositions and methods for the treatment of otic disorders
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.